The Nomination Committee is a committee that acts within the corporate governance area of Zealand Pharma. The current Nomination Committee consists of three members: The General Meeting elects two members of the committee from among the members of the Company's Board of Directors as well as up to three shareholder representatives.
The Nomination Committee specifies the qualifications required and evaluates the skills, knowledge and experience of the individual members of the Board of Directors and the CEO. It also considers proposals submitted by relevant persons, including shareholders, for Board and CEO positions, and identifies and recommends candidates for the Board of Directors.
Following the Annual General Meeting, held on 19 April 2016, the Nomination Committee comprises of the following members:
- Martin Nicklasson, Chairman of the Board of Directors – Chairman of the Nomination Committee
- Peter Benson, Shareholder representative
- Agnete Raaschou-Nielsen, Shareholder representative